lakekvm.blogg.se

Welcome to our first quarter 2023 financial results and business update conference call. It is now my pleasure to introduce our first speaker, Ray Furey, Rigel's Executive Vice President, General Counsel and Corporate Secretary. (Operator Instructions) As a reminder, this conference is being recorded. Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the First Quarter of 2023. Miller Research Analyst Cantor Fitzgerald & Co., Research Division Presentation Riley Securities, Inc., Research Division Furey Executive VP, General Counsel & Corporate Secretary Rigel Pharmaceuticals, Inc.Īllison Marie Bratzel VP and Senior Research Analyst Piper Sandler & Co., Research DivisionĬarly Nicole Kenselaar Analyst Citigroup Inc., Research DivisionĮun Kyung Yang MD & Senior Equity Research Analyst Jefferies LLC, Research Division Rodriguez President, CEO & Director Rigel Pharmaceuticals, Inc. Schorno Executive VP & CFO Rigel Pharmaceuticals, Inc.

Santos Executive VP & Chief Commercial Officer Rigel Pharmaceuticals, Inc.ĭean L.